PPARG and obesity due to melanocortin 4 receptor deficiency: Future studies are needed to confirm the upstream regulator of the BFE-mediated PPARγ pathway, as well as the expression of lipolysis-related genes, which would support the development of BFE for anti-obesity therapy.